Pubertal development and fertility in survivors of childhood acute myeloid leukemia treated with chemotherapy only: A NOPHO-AML study

Pediatric Blood and Cancer

Volumn 60, Issue 12, 2013, Pages 1988-1995

  Molgaard Hansen, Lene ^a   Skou, Anne Sofie ^a   Juul, Anders ^b   Glosli, Heidi ^c   Jahnukainen, Kirsi ^d   Jarfelt, Marianne ^e   Jónmundsson, Gumundur K ^f   Malmros, Johan ^g,h   Nysom, Karsten ⁱ   Hasle, Henrik ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^e QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^f LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^g KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^h KAROLINSKA INSTITUTE   (Sweden)

ⁱ University of Copenhagen   (Denmark)

Author keywords

Acute myeloid leukemia; Children; Fertility; Late effects; Premature ovarian failure; Puberty

Indexed keywords

ANTINEOPLASTIC AGENT; ESTRADIOL; FOLLITROPIN; INHIBIN A; INHIBIN B; LUTEINIZING HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVOR; CHILD; CHILDHOOD CANCER; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; FEMALE; FERTILITY; FOLLOW UP; HORMONE DETERMINATION; HUMAN; LEUKEMIA RELAPSE; MALE; MENARCHE; PARENTHOOD; PREGNANCY; PREMATURE OVARIAN FAILURE; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBERTY; SCHOOL CHILD; SIBLING;

ACUTE MYELOID LEUKEMIA; CHILDREN; FERTILITY; LATE EFFECTS; PREMATURE OVARIAN FAILURE; PUBERTY;

ADOLESCENT; ADULT; ANTI-MULLERIAN HORMONE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; FEMALE; FERTILITY; FOLLICLE STIMULATING HORMONE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; PRIMARY OVARIAN INSUFFICIENCY; PUBERTY; QUESTIONNAIRES; SURVIVORS; YOUNG ADULT;

EID: 84885768557     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24715     Document Type: Article

References (28)

1. Kaspers GJ, Creutzig U. Pediatric acute myeloid leukemia: International progress and future directions. Leukemia 2005; 19:2025-2029.
2. Green DM, Kawashima T, Stovall M, et al. Fertility of male survivors of childhood cancer: A report from the childhood cancer survivor study. J Clin Oncol 2010; 28:332-339.
3. Green DM, Kawashima T, Stovall M, et al. Fertility of female survivors of childhood cancer: A report from the childhood cancer survivor study. J Clin Oncol 2009; 27:2677-2685.
4. Knopman JM, Papadopoulos EB, Grifo JA, et al. Surviving childhood and reproductive-age malignancy: Effects on fertility and future parenthood. Lancet Oncol 2010; 11:490-498.
5. Leung W, Hudson MM, Strickland DK, et al. Late effects of treatment in survivors of childhood acute myeloid leukemia. J Clin Oncol 2000; 18:3273-3279.
6. Leahey AM, Teunissen H, Friedman DL, et al. Late effects of chemotherapy compared to bone marrow transplantation in the treatment of pediatric acute myeloid leukemia and myelodysplasia. Med Pediatr Oncol 1999; 32:163-169.
7. Liesner RJ, Leiper AD, Hann IM, et al. Late effects of intensive treatment for acute myeloid leukemia and myelodysplasia in childhood. J Clin Oncol 1994; 12:916-924.
8. Michel G, Socie G, Gebhard F, et al. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: The impact of conditioning regimen without total-body irradiation-A report from the Societe Francaise de Greffe de Moelle. J Clin Oncol 1997; 15:2238-2246.
9. Klusmann JH, Reinhardt D, Zimmermann M, et al. The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: Results from the AML-BFM 98 study. Haematologica 2012; 97:21-29.
10. Blijdorp K, van Waas M, van der Lely AJ, et al. Endocrine sequelae and metabolic syndrome in adult long-term survivors of childhood acute myeloid leukemia. Leuk Res 2013; 37:367-371.
11. Molgaard-Hansen L, Glosli H, Jahnukainen K, et al. Quality of health in survivors of childhood acute myeloid leukemia treated with chemotherapy only: A NOPHO-AML study. Pediatr Blood Cancer 2011; 57:1222-1229.
12. Sehested A, Juul AA, Andersson AM, et al. Serum inhibin a and inhibin b in healthy prepubertal, pubertal, and adolescent girls and adult women: Relation to age, stage of puberty, menstrual cycle, follicle-stimulating hormone, luteinizing hormone, and estradiol levels. J Clin Endocrinol Metab 2000; 85:1634-1640.
13. Chellakooty M, Schmidt IM, Haavisto AM, et al. Inhibin a, inhibin b, follicle-stimulating hormone, luteinizing hormone, estradiol, and sex hormone-binding globulin levels in 473 healthy infant girls. J Clin Endocrinol Metab 2003; 88:3515-3520.
14. Hagen CP, Aksglaede L, Sorensen K, et al. Serum levels of anti-mullerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 turner syndrome patients. J Clin Endocrinol Metab 2010; 95:5003-5010.
15. Andersson AM, Juul A, Petersen JH, et al. Serum inhibin b in healthy pubertal and adolescent boys: Relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels. J Clin Endocrinol Metab 1997; 82:3976-3981.
16. Sorensen K, Aksglaede L, Petersen JH, et al. Recent changes in pubertal timing in healthy Danish boys: Associations with body mass index. J Clin Endocrinol Metab 2010; 95:263-270.
17. Aksglaede L, Sorensen K, Boas M, et al. Changes in anti-mullerian hormone (AMH) throughout the life span: A population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J Clin Endocrinol Metab 2010; 95:5357-5364.
18. Lie SO, Abrahamsson J, Clausen N, et al. Long-term results in children with AML: NOPHO-AML study group-Report of three consecutive trials. Leukemia 2005; 19:2090-2100.
19. Brougham MF, Wallace WH. Subfertility in children and young people treated for solid and haematological malignancies. Br J Haematol 2005; 131:143-155.
20. Larsen EC, Muller J, Schmiegelow K, et al. Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab 2003; 88:5307-5314.
21. Visser JA, de Jong FH, Laven JS, et al. Anti-mullerian hormone: A new marker for ovarian function. Reproduction 2006; 131:1-9.
22. Kelsey TW, Wright P, Nelson SM, et al. A validated model of serum anti-mullerian hormone from conception to menopause. PLoS ONE 2011; 6:e22024.
23. de Vet A, Laven JS, de Jong FH, et al. Antimullerian hormone serum levels: A putative marker for ovarian aging. Fertil Steril 2002; 77:357-362.
24. Lie Fong S, Laven JS, Hakvoort-Cammel FG, et al. Assessment of ovarian reserve in adult childhood cancer survivors using anti-mullerian hormone. Hum Reprod 2009; 24:982-990.
25. van Casteren NJ, van der Linden GH, Hakvoort-Cammel FG, et al. Effect of childhood cancer treatment on fertility markers in adult male long-term survivors. Pediatr Blood Cancer 2009; 52:108-112.
26. Jorgensen N, Liu F, Andersson AM, et al. Serum inhibin-b in fertile men is strongly correlated with low but not high sperm counts: A coordinated study of 1, 797 European and US men. Fertil Steril 2010; 94:2128-2134.
27. Jahnukainen K, Heikkinen R, Henriksson M, et al. Semen quality and fertility in adult long-term survivors of childhood acute lymphoblastic leukemia. Fertil Steril 2011; 96:837-842.
28. Winther JF, Boice JD Jr, Mulvihill JJ, et al. Chromosomal abnormalities among offspring of childhood-cancer survivors in Denmark: A population-based study. Am J Hum Genet 2004; 74:1282-1285.